Drugs / Penicillin V
Penicillin V
also known as
phenoxymethylpenicillin · penicillin VK · Antibiocin · Beepen vk · Betapen-vk · BICILLIN V2 · Distaquaine v · Fenoximetilpenicilina · +31 more
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | PEN-VEE K | — | 1958-01-13 | fda.gov ↗ |
Trials 10
19561957195819591960196119621963196419651966196719681969197019711972197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT00823433 | Jan → Dec 2009 | group B streptococcal infection | Corewell Health East | Terminated | No outcome recorded Stop: Enrollment |
| Phase 13 trials | ||||||
| Phase 1 | NCT03847610 | Apr → Aug 2018 | — | Imperial College London | Completed | No outcome recorded |
| Phase 1 | NCT01734759 | Nov 2012 → Jan 2013 | — | Mayo Clinic | Completed | No outcome recorded |
| Phase 1 | NCT01499875 | Jan 2012 → Jun 2013 | — | University of Aarhus | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT05693545 | Sep 2023 → Mar 2027 expected | rheumatic heart disease | Children's Hospital Medical Center, Cincinnati | Active not recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03208361 | Nov 2013 → Mar 2016 | pneumonia | Jordi Gol Institute for Primary Care Research | Terminated | No outcome recorded Stop: Enrollment |
| Phase 44 trials · 1 met primary | ||||||
| Phase 4 | NCT06295120 | Nov 2023 → Mar 2026 overdue | pneumonia | Research Unit for General Practice in Aalborg | Recruiting | No outcome recorded |
| Phase 4 | NCT04084106 | Sep 2019 → Nov 2022 | infectious disease | Uppsala University | Completed | No outcome recorded |
| Phase 4 | NCT02712307 | Sep 2015 → Feb 2018 | tonsillitis | Ass. Prof. Katarina Hedin | Completed | Met primary |
| Phase 4 | NCT00552799 | Jul 2006 → Nov 2011 | cellulitis | University of Nottingham | Completed | No outcome recorded |
| Comparator or background therapy11 trials | ||||||
| Phase 0 | NCT02099240 Comparator | Mar 2014 → Nov 2018 | osteomyelitis | University of Louisville | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT02188472 Comparator | Nov 2010 → Feb 2011 | disorder of defective peroxisome oxidative status | Henrik Enghusen Poulsen | Completed | No outcome recorded |
| Phase 3 | NCT07798232 Comparator | Feb 2027 → Jul 2031 expected | rheumatic heart disease | Children's Hospital Medical Center, Cincinnati | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07549594 Comparator | Apr 2026 → Apr 2030 expected | erysipelas | University Hospital, Tours | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT04083417 Comparator | Sep 2019 → Jun 2026 overdue | pharyngitis, tonsillitis | Katarina Hedin | Recruiting | No outcome recorded |
| Phase 4 | NCT02922686 Comparator | Dec 2016 → Dec 2019 | abscess, cellulitis, skin infection | Royal College of Surgeons, Ireland | Unknown | No outcome recorded |
| Phase 4 | NCT02185209 Comparator | Mar 2015 → May 2022 | periodontal disorder | Margareta Hultin | Completed | No outcome recorded |
| Phase 4 | NCT01368341 Comparator | Jun 2011 → Dec 2013 | Borrelia infectious disease, Lyme disease | Morten Lindbaek | Completed | No outcome recorded |
| — | NCT03326661 Comparator | Nov 2017 → Nov 2019 | peritonsillar abscess | Odense University Hospital | Unknown | No outcome recorded |
| — | NCT03293641 Background | May 2016 → Jan 2017 | disorder of zinc metabolism, infectious disease, sickle cell disease | Lucas Otieno Tina, MD MSc | Completed | No outcome recorded |
| — | NCT00615797 Comparator | May 2002 → Dec 2009 | Sydenham chorea, post-bacterial disorder | University of Cape Town | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2015-05-22 | AFT Pharmaceuticals, Ltd. | Regulatory Phenoxymethylpenicillin-AFT (Penicillin V) now in Australia aftpharm.com ↗
In addition to the four products on the Pharmaceutical Schedule, Budenocort Powder for Inhalation, Aramed, Acetadote IV and Provive MCT-LCT. Australia, AFT Pharmaceuticals is delighted to achieve further PBS listings to the four listed, Phenoxymethylpenicillin-AFT (Penicillin V) Oral Liquid 125mg/5ml & 250mg/5ml strengths on the PBS from 01 June 2011. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2015-05-22 | AFT Pharmaceuticals, Ltd. | Phenoxymethylpenicillin-AFT (Penicillin V) now in Australia aftpharm.com ↗ |
Evidence & citations 42 cited values
Every value below carries the sentence it was read from. 24 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Penicillin V | “Folic Acid, Proguanil, Penicillin V, Hydroxyurea over 6 months” NCT03293641 ↗ |
| Known as | Antibiocin | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Beepen vk | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Betapen-vk | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | BICILLIN V2 | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Distaquaine v | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Fenoximetilpenicilina | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Ledercillin vk | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | NSC-757258 | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Oracilline | “Phenoxymethylpenicillin (Oracilline) 1 Million UI twice a day, per os, during one year” NCT07549594 ↗ |
| Known as | PCV | “Patients were assigned to receive one of three antibiotic treatments for 14 days: phenoxymethylpenicillin (PCV), amoxicillin, or doxycycline.” PMID 29505880 ↗ Mar 2018 |
| Known as | Pen-vee k | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Penapar-vk | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Penicillin benzathine phenoxymethyl | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Penicillin phenoxymethyl | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Penicillin potassium phenoxymethyl | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | PENICILLIN V POTASSIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Penicillin v potassium salt | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | penicillin VK | “Penicillin V K 500mg 12hrly po or 250mg 6 hrly for 10 days” NCT00615797 ↗ |
| Known as | Pfizerpen vk | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Phenomycilline | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | phenoxymethylpenicillin | “Participants wore a solid microneedle β-lactam biosensor for up to 6 h while being dosed at steady state with oral phenoxymethylpenicillin (five 500 mg doses every 6 h).” PMID 33323208 ↗ Sep 201912“The purpose of the study is to investigate phenoxymethylpenicillin (the v-penicillin) and trimethoprim's possible induction of oxidative stress in human cells.” NCT02188472 ↗ |
| Known as | Phenoxymethylpenicillin benzathine | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Phenoxymethylpenicillin k | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Phenoxymethylpenicillin potassium | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Phenoxymethylpenicilline | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Phenoxymethylpenicillinum | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Phenoxymethylpenicillinum kalicum | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Potassium penicillin v | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Primcillin | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Uticillin vk | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | V-cillin | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | V-cillin k | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | v-penicillin | “The purpose of the study is to investigate phenoxymethylpenicillin (the v-penicillin) and trimethoprim's possible induction of oxidative stress in human cells.” NCT02188472 ↗ |
| Known as | Vamosyn | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Vebecillin | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Veetids | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Veetids '125' | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Veetids '250' | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Known as | Veetids '500' | ChEMBL registry synonym — accepted as the source's own label CHEMBL615 ↗ |
| Modality | Small molecule | — CHEMBL615 ↗ |
| Route | Oral | “Biconcave tablet 250mg oral, b.d.” NCT00552799 ↗ |